Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01458964 · ClinicalTrials.gov registry record · Phase 4
Quetiapine Compared With Placebo in the Management of Fibromyalgia
A Phase 4 study of Fibromyalgia, sponsored by East Tennessee State University.
- Completed
- Registry status
- Phase 4
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT01458964 is a Phase 4 study of Fibromyalgia that has completed, run by East Tennessee State University. The registered enrollment target is 42 participants, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01458964, a Phase 4 study of Fibromyalgia, has completed, sponsored by East Tennessee State University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
Is quetiapine more effective than other medications in the treatment of fibromyalgia.
Conditions Studied
Interventions
- DRUG Quetiapine
Study Locations (1)
Tennessee
- East Tennessee State University - Johnson City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2008-01 |
| Est. Completion | 2013-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01458964
The ClinicalTrials.gov registry entry for NCT01458964 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (77% lower). The listed sponsor is East Tennessee State University, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 1 intervention - of which Quetiapine is the first listed.
NCT01458964 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT01458964 about?
NCT01458964 is a clinical study titled "Quetiapine Compared With Placebo in the Management of Fibromyalgia". Is quetiapine more effective than other medications in the treatment of fibromyalgia.
What is the current status of trial NCT01458964?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 42 participants. The study started on 2008-01. Estimated completion is 2013-12.
What conditions does trial NCT01458964 study?
This clinical trial studies the following conditions: Fibromyalgia.
What interventions are being tested in trial NCT01458964?
The interventions under investigation include: Quetiapine (DRUG).
Who is sponsoring clinical trial NCT01458964?
This trial is sponsored by East Tennessee State University, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01458964 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fibromyalgia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
COMPLETED · Phase 4
-
A Pilot Study on the Use of Nociceptive Flexion Reflex for Fibromyalgia
COMPLETED · Phase 4
-
Effect of Milnacipran on Pain in Fibromyalgia
COMPLETED · Phase 4
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Auricular Neuromodulation in Veterans With Fibromyalgia
RECRUITING · NA
-
Nitrous Oxide as Treatment for Fibromyalgia
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.